Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurement

v3.22.2
Fair Value Measurement
 6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair Value Measurement
           Fair value ("FV") is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date.
          In determining fair value, the Company uses various valuation approaches and establishes a hierarchy for inputs used in measuring fair value that maximizes the use of relevant observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used, when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the assumptions other market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the observability of inputs as follows:
          Level 1 — Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree of judgment.
          Level 2 — Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
          Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
          A financial instrument's categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
          Our financial instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued and other current liabilities, and long-term debt (if any). The estimated fair value of our financial instruments at June 30, 2022 and December 31, 2021, approximated or equaled their carrying values as reflected in our condensed consolidated balance sheets.
Assets Measured at Fair Value on a Nonrecurring Basis
          Assets measured at fair value on a nonrecurring basis as of June 30, 2022 and December 31, 2021, respectively, are set forth below:
(In thousands)
Estimated fair value measurements
Balance Quoted prices in active market
(Level 1)		 Significant other observable inputs (Level 2) Significant other unobservable inputs (Level 3) Total gains
(losses)
June 30, 2022:
Property and equipment, net $ 11,341  $ —  $ —  $ 11,341  $ (57,454)
December 31, 2021:
Property and equipment, net $ —  $ —  $ —  $ —  $ — 
          Whenever events or circumstances indicate that the carrying value of long-lived assets may not be recoverable, the Company reviews the carrying value of long‑lived assets, such as property and equipment and other assets to determine if they are recoverable. If any long‑lived assets are determined to be unrecoverable, an impairment expense is recorded in the period. As part of the quarterly evaluation for the three months ended June 30, 2022, the Company determined after evaluating existing and new information available that the timely commercialization of its DuraStim® assets, which is included as part of our hydraulic fracturing operations, is no longer reasonably certain, and as such, certain DuraStim® assets may not be recoverable. Our DuraStim® assets are comprised of DuraStim® hydraulic fracturing pumps that utilize electric pressure pumping technology and other ancillary equipment. The Company's DuraStim® technology was first operationally tested at a customer wellsite in 2019, and the DuraStim® hydraulic fracturing pumps' performance did not meet the manufacturer's specifications or our expectations. Although the Company's equipment manufacturer was able to slightly improve the operational performance of the DuraStim® hydraulic fracturing pumps in subsequent tests performed in 2020 and 2021, the overall performance was not consistent with our customers' demands. Given current market conditions, incremental development cost, continued supply chain disruptions, inflation, and other factors impacting further development of our DuraStim® electric technology, the Company does not expect to deploy the equipment in its current form. During the three months ended June 30, 2022, the Company performed an impairment analysis on the DuraStim® hydraulic fracturing pumps that were deemed not recoverable, and compared the carrying value of the DuraStim® hydraulic fracturing pumps with its estimated fair value. The Company determined that the DuraStim® hydraulic fracturing pumps were impaired as the carrying value of the DuraStim® hydraulic fracturing pumps was greater than its estimated fair value. Accordingly, an impairment expense of approximately $57.5 million was recorded, in our pressure pumping reportable segment, for the three months ended June 30, 2022. At June 30, 2022, the estimated fair value of the DuraStim® hydraulic fracturing pumps of $11.3 million was determined using the cost approach, which represents a Level 3 in the fair value measurement hierarchy. Our fair value estimates required us to use significant other unobservable inputs, including assumptions related to replacement cost, among others. The carrying value of our DuraStim® hydraulic fracturing pumps prior to the impairment expense was approximately $68.8 million. No impairment of property and equipment was recorded during the six months ended June 30, 2021.